Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea.
about
Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Randomized, placebo-controlled ...... bowel syndrome with diarrhea.
@en
Randomized, placebo-controlled ...... bowel syndrome with diarrhea.
@nl
type
label
Randomized, placebo-controlled ...... bowel syndrome with diarrhea.
@en
Randomized, placebo-controlled ...... bowel syndrome with diarrhea.
@nl
prefLabel
Randomized, placebo-controlled ...... bowel syndrome with diarrhea.
@en
Randomized, placebo-controlled ...... bowel syndrome with diarrhea.
@nl
P2093
P2860
P1476
Randomized, placebo-controlled ...... e bowel syndrome with diarrhea
@en
P2093
Akito Nishida
Hiraku Akiho
Kei Matsueda
Shin Fukudo
Yoshihiro Nakashima
P2860
P2888
P356
10.1186/S13030-017-0093-9
P50
P577
2017-03-16T00:00:00Z